Role of KATP channels in repetitive induction of ventricular fibrillation

被引:11
作者
Bauer, Alexander
Becker, Ruediger
DreyhaUpt, Jens
Voss, Frederik
Kraft, Patricia
Kelemen, Kamilla
Senges-Becker, Julia C.
Katus, Hugo A.
Schoels, Wolfgang
机构
[1] Heidelberg Univ, Dept Cardiol, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Dept Med Biometry & Informat, D-6900 Heidelberg, Germany
来源
EUROPACE | 2007年 / 9卷 / 03期
关键词
K-ATP channels; HMR; 1883; ventricular fibrillation; arrhythmias;
D O I
10.1093/europace/eul146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim Patients with sustained ventricular tachyarrhythmias are at high risk for sudden cardiac death. The mechanisms leading to multiple temporally related episodes of ventricular fibrillation (VF) are not yet fully elucidated, and treatment options are limited. We investigated whether K-ATP-channels could be involved in triggering VF. Methods We determined postarrhythmic changes of monophasic action potentials (MAP) after repetitive induction of VF in 32 Langendorff-perfused rabbit hearts. Results Postarrhythmic action potential duration (APD) was significantly shorter compared with baseline (100 +/- 12 ms vs. 140 +/- 8 ms, P < 0.05). With increasing numbers of VF and shortening of recovery intervals between VF episodes (2 min) inducibility of VF increased, and abbreviation of APD became more prominent (90 +/- 5 ms vs. 130 +/- 4 ms, P < 0.05). Pre-treatment with the selective K-ATP blocking agent HMR 1883 led to a significant increase of postarrhythmic APDs compared with control hearts (100 +/- 12 ms vs. 118 +/- 3 ms, P = 0.0013). Moreover, HMR 1883 significantly reduced inducibility of VF and increased the rate of successful defibrillation. Conclusions Repetitive episodes of VF result in postarrhythmic abbreviation of APDs, a phenomenon thought to be of potential relevance for incessant tachyarrhythmias in patients. Prevention of postarrhythmic MAP-shortening by HMR 1883 might be useful in suppressing VF.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 24 条
[1]   CLONING OF THE BETA-CELL HIGH-AFFINITY SULFONYLUREA RECEPTOR - A REGULATOR OF INSULIN-SECRETION [J].
AGUILARBRYAN, L ;
NICHOLS, CG ;
WECHSLER, SW ;
CLEMENT, JP ;
BOYD, AE ;
GONZALEZ, G ;
HERRERASOSA, H ;
NGUY, K ;
BRYAN, J ;
NELSON, DA .
SCIENCE, 1995, 268 (5209) :423-426
[2]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[3]   GLUCOSE INDUCES CLOSURE OF SINGLE POTASSIUM CHANNELS IN ISOLATED RAT PANCREATIC BETA-CELLS [J].
ASHCROFT, FM ;
HARRISON, DE ;
ASHCROFT, SJH .
NATURE, 1984, 312 (5993) :446-448
[4]   Effects of a novel cardioselective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido) ethyl]-β-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia:: In vitro and in vivo studies [J].
Billman, GE ;
Houle, MS ;
Englert, HC ;
Gögelein, H .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01) :182-192
[5]   ROLE OF ATP-SENSITIVE POTASSIUM CHANNEL IN EXTRACELLULAR POTASSIUM ACCUMULATION AND CARDIAC-ARRHYTHMIAS DURING MYOCARDIAL-ISCHEMIA [J].
BILLMAN, GE .
CARDIOVASCULAR RESEARCH, 1994, 28 (06) :762-769
[6]   HETEROGENEITY IN EXTRACELLULAR POTASSIUM CONCENTRATION DURING EARLY MYOCARDIAL-ISCHEMIA AND REPERFUSION - IMPLICATIONS FOR ARRHYTHMOGENESIS [J].
CORONEL, R .
CARDIOVASCULAR RESEARCH, 1994, 28 (06) :770-777
[7]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788
[8]  
EPSTEIN AE, 1995, CARDIAC ELECTROPHYSI, P927
[9]  
Exner DV, 2001, CIRCULATION, V103, P2066
[10]   INVITRO VALIDATION OF A NEW CARDIAC CATHETER TECHNIQUE FOR RECORDING MONOPHASIC ACTION-POTENTIALS [J].
FRANZ, MR ;
BURKHOFF, D ;
SPURGEON, H ;
WEISFELDT, ML ;
LAKATTA, EG .
EUROPEAN HEART JOURNAL, 1986, 7 (01) :34-41